# Non-Interventional Study of Puzol-cel for CD19-Positive Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

> clinical trial · VERIFIED · 2026-06-10

Status: NOT_YET_RECRUITING · Sponsor: Chongqing Precision Biotech Co., Ltd · Condition: Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (r/r B-ALL)

- Company: Chongqing Precision Biotech Co., Ltd
- Sector: cell therapy
- Primary source: https://clinicaltrials.gov/study/NCT07637929

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.